Published in Gastrointest Endosc on March 01, 2009
19 Versus 22-Gauge Needle for EUS-LB (EUSLB1922) | NCT02967991
Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811
Comparison of 19g FNA and 19g FNB Needles for EUS-LB | NCT03408171
Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle | NCT03910790
EUS-guided liver biopsy: a procedure looking for an indication. Gastrointest Endosc (2009) 1.08
Needle-based confocal laser endomicroscopy to assess liver histology in vivo. Gastrointest Endosc (2010) 0.85
Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound (2015) 0.81
Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open (2015) 0.81
Imaging-guided Parenchymal Liver Biopsy: How We Do It. J Clin Imaging Sci (2011) 0.79
Usefulness of endoscopic ultrasonography in hepatology. Can J Gastroenterol (2011) 0.79
Usefulness of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of hepatic, gallbladder and biliary tract Lesions. World J Gastrointest Oncol (2014) 0.76
What is the current role of endoscopy in primary sclerosing cholangitis? World J Gastrointest Endosc (2015) 0.76
Endoscopic ultrasound-guided liver biopsy in pediatric patients. Endosc Ultrasound (2014) 0.75
EUS Trucut biopsy liver parenchyma acquisition and yield are comparable to that of a transjugular liver biopsy. Gastrointest Endosc (2009) 0.75
Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass. Endosc Ultrasound (2017) 0.75
Role of endoscopic ultrasound in liver disease: Where do we stand in 2017? World J Hepatol (2017) 0.75
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med (2010) 13.33
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis. Gastroenterology (2012) 3.49
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf (2009) 3.48
ERCP for gallstone pancreatitis. N Engl J Med (2014) 3.37
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology (2004) 3.25
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2011) 2.97
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (2009) 2.92
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc (2007) 2.77
Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol (2006) 2.70
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology (2008) 2.66
Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 2.46
Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (2011) 2.44
Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med (2004) 2.44
Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series. Gastrointest Endosc (2008) 2.44
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc (2005) 2.27
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology (2011) 2.25
Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med (2009) 2.23
Learning curves for EUS by using cumulative sum analysis: implications for American Society for Gastrointestinal Endoscopy recommendations for training. Gastrointest Endosc (2012) 2.16
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg (2007) 2.10
Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc (2004) 2.04
Endoscopic therapy with 2-octyl-cyanoacrylate for the treatment of gastric varices. Dig Dis Sci (2014) 1.99
EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc (2006) 1.93
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology (2010) 1.91
Functional gallbladder and sphincter of oddi disorders. Gastroenterology (2006) 1.87
Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology (2008) 1.87
Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc (2009) 1.85
Individual and practice differences among physicians who perform ERCP at varying frequency: a national survey. Gastrointest Endosc (2011) 1.82
Nurse-administered propofol sedation compared with midazolam and meperidine for EUS: a prospective, randomized trial. Gastrointest Endosc (2008) 1.82
ERCP via gastrostomy vs. double balloon enteroscopy in patients with prior bariatric Roux-en-Y gastric bypass surgery. Surg Endosc (2013) 1.81
Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc (2006) 1.79
An assessment of statin safety by hepatologists. Am J Cardiol (2006) 1.78
Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology (2009) 1.78
Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Gastrointest Endosc (2007) 1.78
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci (2005) 1.76
Effects of droperidol on the pancreatic and biliary sphincters. Gastrointest Endosc (2003) 1.74
Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int (2005) 1.71
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology (2008) 1.70
Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc (2002) 1.70
Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study. Gastrointest Endosc (2012) 1.70
Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc (2003) 1.65
Quality in EUS: an assessment of baseline compliance and performance improvement by using the American Society for Gastrointestinal Endoscopy-American College of Gastroenterology quality indicators. Gastrointest Endosc (2009) 1.65
Role of endoscopic ultrasound-guided fine-needle aspiration with flow cytometry to diagnose lymphoma: a single center experience. J Gastroenterol Hepatol (2009) 1.65
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology (2007) 1.60
Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology (2009) 1.59
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology (2010) 1.58
Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis. Pancreas (2003) 1.56
Lipid-lowering agents that cause drug-induced hepatotoxicity. Clin Liver Dis (2007) 1.56
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc (2005) 1.54
Association between volume of endoscopic retrograde cholangiopancreatography at an academic medical center and use of pancreatobiliary therapy. Clin Gastroenterol Hepatol (2012) 1.53
Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci (2011) 1.52
A prospective randomized trial of 1 versus 2 injections during EUS-guided celiac plexus block for chronic pancreatitis pain. Gastrointest Endosc (2009) 1.52
Acute pancreatitis after removal of retained prophylactic pancreatic stents. Gastrointest Endosc (2011) 1.51
Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology (2008) 1.50
Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc (2004) 1.49
Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography. Am J Respir Crit Care Med (2004) 1.49
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol (2004) 1.48
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol (2010) 1.48
Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction. Gastrointest Endosc (2003) 1.46
Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2015) 1.46
Langerhans' cell histiocytosis involving the pituitary, thyroid, lung, and liver. Endocr Pract (2002) 1.45
Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Clin Gastroenterol (2004) 1.43
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci (2013) 1.40
ERCP findings in idiopathic pancreatitis: patients who are cystic fibrosis gene positive and negative. Gastrointest Endosc (2006) 1.40
Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt. J Clin Gastroenterol (2011) 1.38
Therapeutic EUS-assisted endoscopic retrograde pancreatography after failed pancreatic duct cannulation at ERCP. Gastrointest Endosc (2010) 1.36
EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc (2009) 1.32